BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24038070)

  • 1. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.
    Zhu X; Zhang F; Zhang W; He J; Zhao Y; Chen X
    J Surg Oncol; 2013 Nov; 108(6):387-97. PubMed ID: 24038070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas.
    Nakata Y; Uzawa N; Takahashi K; Sumino J; Michikawa C; Sato H; Sonoda I; Ohyama Y; Okada N; Amagasa T
    Eur J Cancer; 2011 Oct; 47(15):2364-72. PubMed ID: 21852109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.
    Zang J; Li C; Zhao LN; Shi M; Zhou YC; Wang JH; Li X
    Head Neck; 2013 Oct; 35(10):1507-14. PubMed ID: 22987573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
    Agulnik M; da Cunha Santos G; Hedley D; Nicklee T; Dos Reis PP; Ho J; Pond GR; Chen H; Chen S; Shyr Y; Winquist E; Soulieres D; Chen EX; Squire JA; Marrano P; Kamel-Reid S; Dancey J; Siu LL; Tsao MS
    J Clin Oncol; 2007 Jun; 25(16):2184-90. PubMed ID: 17538163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
    Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
    J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
    Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
    Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER3 overexpression and survival in solid tumors: a meta-analysis.
    Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
    J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.
    Hong L; Han Y; Yang J; Zhang H; Jin Y; Brain L; Li M; Zhao Q
    Gene; 2013 Oct; 529(1):69-72. PubMed ID: 23954221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.
    Issing WJ; Liebich C; Wustrow TP; Ullrich A
    Anticancer Res; 1996; 16(1):283-8. PubMed ID: 8615622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.
    Mrhalova M; Plzak J; Betka J; Kodet R
    Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.